Why some people don’t lose weight with Wegovy
Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
The Economist10h
Wegovy hits the People’s Republic, at last
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Northern lights forecast to be visible in much of Canada this weekend
The northern lights could be visible for residents in northern and upper Midwest states in the U.S. as early as Thursday, ...
Northern lights forecast to fill the skies in Midwest U.S., some areas in Canada
The northern lights could be visible for residents in northern and upper Midwest states in the U.S. as early as Thursday, ...
Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
Health Canada has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of non-fatal heart attack, the drug ...
Voice Online1d
Health Canada approves Wegovy (semaglutide injection) to reduce risk of non-fatal myocardial infarction
NOVO Nordisk on Wednesday announced that Wegovy (semaglutide injection) is now approved to reduce the risk of non-fatal ...
Wegovy approved in Canada to combat risk of non fatal-heart attack
Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial ...
Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
Global News on MSN1d
Health Matters: Wegovy approved to reduce heart attack risk
Novo Nordisk says Health Canada has approved its weight loss drug Wegovy to reduce the risk of heart attacks in some adults. Kyle Benning has the details and more in Health Matters for Nov. 27, 2024.